Torsion dystonia is one of the most common and least well understood of movement disorders in humans. Affected individuals manifest contracted, twisting postures due to abnormal neurotransmission in the basal ganglia. Early onset torsion dystonia, the most common and severe of the hereditary dystonias, is a dominant disorder with reduced penetrance that manifests during a window of childhood development. Most cases of this disease are caused by inframe deletions in the DYT1 (TORIA) gene, which encodes a novel AAA+ chaperone protein, torsinA, with three homologous family members. The goals of this Program are to elucidate the location and function of torsinA in the nervous system during development and adult life, and to determine how mutations in torsinA perturb these functions. Our hypothesis is that defects in torsinA interfer with vesicle trafficking causing abnormal release of dopamine in the striatum, and, in turn, to alterations in the modeling of neuronal circuitry in the basal ganglia with subsequent compromise of motor control and learning. One Project will focus on determining whether torsinA is a component of vesicle trafficking and release mechanisms, and how expression of mutant torsinA affects signaling, receptor density and dopamine homeostasis in the striatum of humans and mouse models. A Second Project will investigate the distribution of the torsins in the developing mouse brain and how expression of mutant torsinA affects neuronal migration, process extension and synaptogenesis in targeted regions using transgenic mice and knock-out. A Third Project will explore the role of torsin in development of the nervous system in Drosophila and in protein trafficking in specific neuronal populations, and identify genes which can modify torsin-related functions. A Fourth Project will generate and characterize transgenic and conditional knock-out mice for torsinA with respect to motor control and learning and in response to pharmacologic manipulations of dopamine receptors. These Projects will be supported by an administrative core, and cores for biochemistry and antibody generation and clinical sample collection, databasing and pilot studies. Findings should provide insight into dysfunction of dopaminergic neurons, also involved in Parkinson's disease, and potential therapeutic interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS037409-07
Application #
7083713
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Tagle, Danilo A
Project Start
2000-01-01
Project End
2009-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
7
Fiscal Year
2006
Total Cost
$1,378,840
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Waugh, Jeff L; Kuster, John K; Levenstein, Jacob M et al. (2016) Thalamic Volume Is Reduced in Cervical and Laryngeal Dystonias. PLoS One 11:e0155302
Sundermann, Erin Elizabeth; Wang, Cuiling; Katz, Mindy et al. (2016) Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ?4 on memory decline in older adults. Neurobiol Aging 41:200.e7-200.e12
DeAndrade, Mark P; Trongnetrpunya, Amy; Yokoi, Fumiaki et al. (2016) Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia. Mov Disord 31:1633-1639
de Carvalho Aguiar, Patricia; Borges, Vanderci; Ferraz, Henrique Ballalai et al. (2015) Novel compound heterozygous mutations in PRKRA cause pure dystonia. Mov Disord 30:877-8
Alcalay, Roy N; Mejia-Santana, Helen; Mirelman, Anat et al. (2015) Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. Parkinsonism Relat Disord 21:106-10
Saunders-Pullman, Rachel; Alcalay, Roy N; Mirelman, Anat et al. (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834-9
Gupte, Manisha; Alcalay, Roy N; Mejia-Santana, Helen et al. (2015) Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives. J Genet Couns 24:238-46
Mirelman, Anat; Alcalay, Roy N; Saunders-Pullman, Rachel et al. (2015) Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Mov Disord 30:981-6
Yokoi, Fumiaki; Dang, Mai T; Liu, Jun et al. (2015) Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ?GAG heterozygous knock-in mice. Behav Brain Res 279:202-10
Yokoi, Fumiaki; Chen, Huan-Xin; Dang, Mai Tu et al. (2015) Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice. PLoS One 10:e0120916

Showing the most recent 10 out of 82 publications